After the first day of Senate confirmation hearings for Jeff Sessions, president-elect Trump's choice to lead the US Justice Department, cannabis advocates are parsing his testimony for clues as to what the incoming administration's stance will be on whether to continue to give breathing room to state-level legalization and medical marijuana laws. The Los Angeles Times takes an ominous view, writing in a headline: "Sessions leaves door open to reviving federal war on pot."

President-elect Donald Trump's transition team announced Nov. 18 that Alabama Sen. Jeff Sessions has been named to the post of attorney general. The Republican former US attorney was the first senator to throw his support behind Trump's presidential bid, and he later worked with the candidate to craft his policies on immigration and counter-terrorism. Sessions must face a confirmation hearing before the Senate Judiciary Committee, where his past inflammatory remarks concerning race and his support for mass deportation of undocumented immigrants may stir opposition. Still, he should be confirmed, as Republicans will likely have a 52-48 advantage over Democrats in the committee.

For a second year running, the US Border Patrol reports drastically reduced cannabis seizures along the Mexican border—and even the mainstream media can't help making the connection to the growing trend toward legalization and tolerance in the United States. In reporting the findings, the Washington Post uses the headline, "Legal marijuana is finally doing what the drug war couldn't." Last year, border agents confiscated some 1.5 million pounds—down from a peak of nearly 4 million in 2009. Increased domestic production in California, Colorado and Washington have driven prices down, especially at the bulk level. "Two or three years ago, a kilogram [2.2 pounds] of marijuana was worth $60 to $90," a Mexican cannabis farmer recently told NPR. "But now they're paying us $30 to $40 a kilo. It's a big difference. If the U.S. continues to legalize pot, they'll run us into the ground."

The House and Senate appropriations leadership has hammered out a budget bill that includes an historic amendment to curb federal Department of Justice (DoJ) enforcement in medical marijuana states. The measure, which was originally passed by the House in May with a 219-189 vote, aims to prohibit the DoJ from spending taxpayer money to undermine state medical marijuana laws. "This is great news for medical marijuana patients all across the country," said Rep. Sam Farr (D-CA), one of the co-authors of the House measure. "This amendment protects patients while the federal government catches up with the views of the American people. Patients will have access to the care legal in their state without fear of federal prosecution. And our federal dollars will be spent more wisely on fighting actual crimes and not wasted going after patients."

Reaction continues to mount to news that Bob Marley's name is to be further immortalized as a cannabis brand—not just a strain, but an actual brand name. Privateer Holdings, a Seattle-based private equity firm that invests in the cannabis industry, has struck a deal with the estate of the late reggae superstar to launch a global marijuana brand, Financial Times reports. The firm's Marley Natural subsidiary will start marketing its line next year, including "heirloom Jamaican cannabis strains," cannabis-infused skin creams and lip balms, and accessories such as vaporizers and pipes "based on those that Bob preferred." (Oh? Did Bob vape? Really?) Privateer CEO Brendan Kennedy said he is interested in markets including the Netherlands, Uruguay, Canada, Spain and Israel.

On New Year’s Day, as retail sales of cannabis went legal in Colorado, the state's dispensaries registered well over $1 million in sales. Despite cold and wet weather, most of the 36 shops that opened that day reported long lines, with some customers waiting outdoors for hours. By the end of the first week, by which time another dozen retail outlets had opened, the figure was a whopping $5 million. More than 100 dispensaries in the Centennial State have now received licenses for retail cannabis sales and over 500 are eligible to apply. More are applying every day.

"A new industry is developing in a nascent state in Colorado," says Rachel Gillette, director of the Colorado chapter of the National Organization for the Reform of Marijuana Laws (NORML). "We're not just talking about retail sales, but a lot of other types of business associated with it—construction companies, HVAC contractors, nutrient companies, lighting and equipment sales, packaging, printers, labeling, marketing materials, websites, marijuana tourism, attorneys, payroll companies… This could represent a lot of jobs."

The US District Court for the Eastern District of California will hold rare formal hearings beginning Oct. 27 to determine whether an indictment against Brian Justin Pickard and others for conspiracy to grow more than 1,000 marijuana plants violates the US Constitution, and whether marijuana is misclassified by the federal government as a dangerous drug with no medical value. US District Judge Kimberly J. Mueller will preside over the three-day hearing, which includes expert testimony from doctors Carl Hart, associate professor of psychology at Columbia University in New York; Greg Carter, medical director of St. Luke's Rehabilitation Institute in Spokane, Wash., and expert witness Chris Conrad.

In an unprecedented 219-189 floor vote late May 29, the House of Representatives approved the end of funding for Department of Justice (DoJ) enforcement in medical marijuana states. Advocates are hailing the vote as a major victory that signals a shift in the approach Congress is taking on this issue. The vote was on Amendment No. 25 to the Commerce, Justice & Science (CJS) appropriations bill. One hundred seventy Democrats and 49 Republicans voted in favor of the amendment. "This Congressional vote is a huge victory for patients," said Steph Sherer, executive director of Americans for Safe Access. "No longer will we have to look over our shoulder and worry when the next raid or indictment will prevent us from safely and legally accessing our medicine. This is a game-changer that paves the way for much more policy change to come."